Inhibition of BET bromodomain targets genetically diverse glioblastoma.
Cheng, Zhixiang
Inhibition of BET bromodomain targets genetically diverse glioblastoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Apr 2013 - 1748-59 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-12-3066 doi
Animals
Azepines--administration & dosage
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Disease Models, Animal
Disease Progression
Drug Resistance, Neoplasm--genetics
Female
Gene Expression Regulation, Neoplastic--drug effects
Gene Knockdown Techniques
Glioblastoma--drug therapy
Humans
Mice
Protein Kinase Inhibitors--administration & dosage
Protein Serine-Threonine Kinases--antagonists & inhibitors
Proto-Oncogene Proteins c-myc--metabolism
RNA Interference
Signal Transduction--drug effects
Transcription, Genetic--drug effects
Triazoles--administration & dosage
Xenograft Model Antitumor Assays
Inhibition of BET bromodomain targets genetically diverse glioblastoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Apr 2013 - 1748-59 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-3265
10.1158/1078-0432.CCR-12-3066 doi
Animals
Azepines--administration & dosage
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Disease Models, Animal
Disease Progression
Drug Resistance, Neoplasm--genetics
Female
Gene Expression Regulation, Neoplastic--drug effects
Gene Knockdown Techniques
Glioblastoma--drug therapy
Humans
Mice
Protein Kinase Inhibitors--administration & dosage
Protein Serine-Threonine Kinases--antagonists & inhibitors
Proto-Oncogene Proteins c-myc--metabolism
RNA Interference
Signal Transduction--drug effects
Transcription, Genetic--drug effects
Triazoles--administration & dosage
Xenograft Model Antitumor Assays